Your browser doesn't support javascript.
loading
Shaping Functional Avidity of CAR T Cells: Affinity, Avidity, and Antigen Density That Regulate Response.
Greenman, Raanan; Pizem, Yoav; Haus-Cohen, Maya; Goor, Alona; Horev, Guy; Denkberg, Galit; Sinik, Keren; Elbaz, Yael; Bronner, Vered; Levin, Anat Globerson; Horn, Galit; Shen-Orr, Shai; Reiter, Yoram.
Afiliación
  • Greenman R; Laboratory of Molecular Immunology, Faculty of Biology, Technion-Israel Institute of Technology, Haifa, Israel.
  • Pizem Y; Laboratory of Molecular Immunology, Faculty of Biology, Technion-Israel Institute of Technology, Haifa, Israel.
  • Haus-Cohen M; Laboratory of Molecular Immunology, Faculty of Biology, Technion-Israel Institute of Technology, Haifa, Israel.
  • Goor A; Laboratory of Molecular Immunology, Faculty of Biology, Technion-Israel Institute of Technology, Haifa, Israel.
  • Horev G; Laboratory of Molecular Immunology, Faculty of Biology, Technion-Israel Institute of Technology, Haifa, Israel.
  • Denkberg G; Adicet Bio Israel Ltd, Haifa, Israel.
  • Sinik K; Adicet Bio Israel Ltd, Haifa, Israel.
  • Elbaz Y; Adicet Bio Israel Ltd, Haifa, Israel.
  • Bronner V; Bio-Rad, Haifa, Israel.
  • Levin AG; Tel Aviv Sourasky Medical Center (TASMC), Tel Aviv, Israel.
  • Horn G; Tel Aviv Sourasky Medical Center (TASMC), Tel Aviv, Israel.
  • Shen-Orr S; Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
  • Reiter Y; Laboratory of Molecular Immunology, Faculty of Biology, Technion-Israel Institute of Technology, Haifa, Israel. reiter@technion.ac.il.
Mol Cancer Ther ; 20(5): 872-884, 2021 05.
Article en En | MEDLINE | ID: mdl-33649106
ABSTRACT
Chimeric antigen receptors (CARs) are immunoreceptors that redirect T cells to selectively kill tumor cells. Given their clinical successes in hematologic malignancies, there is a strong aspiration to advance this immunotherapy for solid cancers; hence, molecular CAR design and careful target choice are crucial for their function. To evaluate the functional significance of the biophysical properties of CAR binding (i.e., affinity, avidity, and antigen density), we generated an experimental system in which these properties are controllable. We constructed and characterized a series of CARs, which target the melanoma tumor-associated antigen Tyr/HLA-A2, and in which the affinity of the single-chain Fv binding domains ranged in KD from 4 to 400 nmol/L. These CARs were transduced into T cells, and each CAR T-cell population was sorted by the level of receptor expression. Finally, the various CAR T cells were encountered with target cells that present different levels of the target antigen. We detected nonmonotonic behaviors of affinity and antigen density, and an interrelation between avidity and antigen density. Antitumor activity measurements in vitro and in vivo corroborated these observations. Our study contributes to the understanding of CAR T-cell function and regulation, having the potential to improve therapies by the rational design of CAR T cells.See related article on p. 946.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T / Receptores Quiméricos de Antígenos / Antígenos de Neoplasias Límite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2021 Tipo del documento: Article País de afiliación: Israel

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T / Receptores Quiméricos de Antígenos / Antígenos de Neoplasias Límite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2021 Tipo del documento: Article País de afiliación: Israel